Simon Senanu: Understanding the Extrinsic Coagulation Pathway
Simon Senanu, Medical Laboratory Scientist at Perkins Medical Centre, shared a post on LinkedIn:
”Prothrombin Time (PT) and INR – Understanding the Extrinsic Pathway
Hemostasis involves a coordinated sequence of reactions that lead to clot formation and stabilization.
One of the most commonly used laboratory tests for evaluating this process is the Prothrombin Time (PT).
PT assesses the extrinsic and common pathways of the coagulation cascade, making it an essential test in diagnosing bleeding disorders and monitoring anticoagulant therapy.
What Is Prothrombin Time (PT)?
Prothrombin Time measures the time required for plasma to clot after the addition of tissue factor (thromboplastin) and calcium.
This test evaluates the activity of several clotting factors, including:
- Factor I (Fibrinogen)
- Factor II (Prothrombin)
- Factor V
- Factor VII
- Factor X
Because Factor VII belongs to the extrinsic pathway, PT is particularly sensitive to abnormalities affecting this pathway.
Principle of the Test In the laboratory:
- Citrated plasma is obtained from the patient sample
- Tissue thromboplastin and calcium are added
- The time taken for fibrin clot formation is measured
The result is reported in seconds and often converted to the International Normalized Ratio (INR) for standardization.
What Is INR?
The International Normalized Ratio (INR) was developed to standardize PT results between different laboratories and reagents.
INR allows clinicians to monitor patients receiving oral anticoagulants such as warfarin more reliably.
Typical values include:
- Normal individuals: INR ≈ 0.8 – 1.2
- Patients on warfarin therapy: INR 2.0 – 3.0 (depending on indication)
Causes of Prolonged PT
Prolonged PT may occur in conditions affecting the extrinsic or common coagulation pathways, including:
- Vitamin K deficiency
- Liver disease
- Warfarin therapy
- Disseminated intravascular coagulation (DIC)
- Factor VII deficiency
- Severe clotting factor depletion
Because many clotting factors are synthesized in the liver, PT is often used as a marker of hepatic synthetic function.
Pre-Analytical Considerations
Accurate PT results depend on proper sample handling. Important factors include:
- Correct blood-to-anticoagulant ratio (9:1)
- Proper mixing of citrated blood
- Avoiding hemolysis or clot formation in the tube
- Prompt plasma separation
Errors during collection or processing may lead to falsely prolonged results.
Laboratory Takeaway
Prothrombin Time is a key tool for evaluating extrinsic pathway defects and monitoring anticoagulant therapy.
When interpreted alongside other coagulation tests such as Activated Partial Thromboplastin Time (aPTT) and D-dimer, it helps provide a clearer picture of the patient’s hemostatic status.”

Other posts featuring Simon Senanu on Hemostasis Today.
-
Aug 8, 2026, 20:37Tammuella Chrisentery-Singleton: What Comes Next for Hemophilia Care With Non-Factor Therapies?
-
Aug 8, 2026, 20:36Michelle Cha: The Evolving Role of Nurse Coordinators in Hemophilia Gene Therapy
-
Aug 8, 2026, 20:35Benjamin Schumacher: The Future of Holistic Haemophilia A Care
-
Aug 8, 2026, 20:33Delilah F.: March Is Blood Clot Awareness Month
-
Aug 8, 2026, 20:31Jackie Maybin: Top 10 Research Priorities for Problematic Menstrual Bleeding in the UK
-
Aug 8, 2026, 17:02Mohammed Murad Hossain: Highlights from the 2nd Haematology and HSCT Workshop in Dhaka
-
Aug 8, 2026, 16:57Mohammed Al Kanan: Advancing Therapeutic Drug Monitoring in Pediatric Aplastic Anemia
-
Aug 8, 2026, 16:38Dmytro Samofalov: FDA-Approved Freeze-Dried Plasma in Modern Warfare
-
Aug 8, 2026, 16:33Roshan Koshy Jacob: When Unexplained Severe Anemia Points to Myelodysplastic Neoplasms